Literature DB >> 20378247

Upregulations of P2X(3) and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats.

Kiyomi Hori1, Noriyuki Ozaki, Shigeyuki Suzuki, Yasuo Sugiura.   

Abstract

The role of ion channels expressed in sensory neurons on mechanical and thermal hyperalgesia was examined in a rat model of cisplatin-induced peripheral neuropathy. The rats were injected with 3mg/kg of cisplatin intraperitoneally once per week for five consecutive weeks. The von Frey test, pin-prick test and plantar test were performed to examine any noxious sensitivity of the skin. The Randall-Selitto test of the gastrocnemius muscle (GM) and the measurement of grip forces were performed to quantify muscle hyperalgesia. Coordination/motor was assessed by Rota-rod testing. Expressions of the ion channels TRPV1, TRPV2, P2X(3) and ASIC3 were examined in dorsal root ganglion (DRG) neurons and the muscle afferent neurons innervating GM. Effects of antagonists against either P2X(3) or ASICs on behavioral responses were evaluated. Mechanical hyperalgesia and allodynia of both skin and muscle were observed in cisplatin-treated animals. Expressions of TRPV2, P2X(3), and ASIC3 increased in all DRG neurons. In addition, expressions of P2X(3) and ASIC3 also increased in muscle afferent neurons in DRGs. Antagonists against P2X(3,2/3) and ASICs showed a suppressive effect on both skin and muscle hyperalgesia induced by cisplatin administration. Upregulation of TRPV2, P2X(3), and ASIC3 may play important roles in the mechanical hyperalgesia induced by cisplatin. Furthermore, cisplatin treatment also induced muscle hyperalgesia in muscle afferent neurons in connection with the upregulation of P2X(3) and ASIC3. Copyright 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378247     DOI: 10.1016/j.pain.2010.03.005

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  23 in total

Review 1.  Rise of the sensors: nociception and pruritus.

Authors:  James N Baraniuk
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 2.  Emerging trends in understanding chemotherapy-induced peripheral neuropathy.

Authors:  Jérémy Ferrier; Vanessa Pereira; Jérome Busserolles; Nicolas Authier; David Balayssac
Journal:  Curr Pain Headache Rep       Date:  2013-10

3.  Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia.

Authors:  Min-Suk Yoon; Lars Bechmann; Mark Obermann; Olivia Yepnjouo; Rupert Egensperger; Guido Gerken; Zaza Katsarava; Juergen Thomale; Gerald Holtmann
Journal:  Neurosci Bull       Date:  2010-08       Impact factor: 5.203

4.  Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy.

Authors:  Megan L Uhelski; Iryna A Khasabova; Donald A Simone
Journal:  J Neurophysiol       Date:  2014-12-10       Impact factor: 2.714

5.  Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept.

Authors:  Hue Jung Park; Jennifer A Stokes; Elaine Pirie; James Skahen; Yuri Shtaerman; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-12-07       Impact factor: 5.108

6.  Enhancement of purinergic signalling by excessive endogenous ATP in resiniferatoxin (RTX) neuropathy.

Authors:  Chih-Lung Lin; Yaw-Syan Fu; Tin-Hsin Hsiao; Yu-Lin Hsieh
Journal:  Purinergic Signal       Date:  2012-12-20       Impact factor: 3.765

Review 7.  ASICs Mediate Pain and Inflammation in Musculoskeletal Diseases.

Authors:  Ramy E Abdelhamid; Kathleen A Sluka
Journal:  Physiology (Bethesda)       Date:  2015-11

8.  Mitigation of cisplatin-induced peripheral neuropathy by canagliflozin in rats.

Authors:  Ahmed A Abdelsameea; Soad L Kabil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-03       Impact factor: 3.000

9.  Spinal serum-inducible and glucocorticoid-inducible kinase 1 mediates neuropathic pain via kalirin and downstream PSD-95-dependent NR2B phosphorylation in rats.

Authors:  Hsien-Yu Peng; Gin-Den Chen; Cheng-Yuan Lai; Ming-Chun Hsieh; Tzer-Bin Lin
Journal:  J Neurosci       Date:  2013-03-20       Impact factor: 6.167

10.  Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons.

Authors:  Fang Qiu; Chun-Yu Qiu; Huilan Cai; Ting-Ting Liu; Zu-Wei Qu; Zhifan Yang; Jia-Da Li; Qun-Yong Zhou; Wang-Ping Hu
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.